MPR delivers practical, up-to-date drug information to healthcare professionals. Using the expertise gained from 25 years of providing point-of-care drug tools, MPR has now created a drug review course exclusively for See below for a list of each quarter's courses. Click here to visit MPR's website.

Latest Courses

MPR Drug News

Certain Foods Tied to Increased Depression Risk

The authors found that a diet which includes large amounts of fruits, vegetables, whole grains, fish, olive oil, low-fat dairy, antioxidants and low intake of animal foods appeared to be associated with a reduced risk of depression.

Pelvic Inflammatory Disease: Antibiotic Regimens Compared

Study authors found no conclusive evidence for the use of nitroimidazoles (eg, metronidazole) vs. other agents with activity over anaerobes.

FDA Cracking Down on Cancer 'Cures'

These claims violate the Federal Food, Drug and Cosmetic Act to sell products that claim to prevent, diagnose, treat, mitigate or cure diseases without first demonstrating to the Agency that they are safe and effective for their labeled indications.

FDA Approves Once-Monthly Dosing for Praluent

The FDA approval was supported by data from the Phase 3 ODYSSEY CHOICE I study that examined Praluent 300mg every 4 weeks vs. placebo in patients with hypercholesterolemia.

Guidelines on Sudden Unexpected Death in Epilepsy Released

The greatest risk factor for SUDEP was found to be generalized tonic-clonic seizures (GTCS), with a higher frequency of these types of seizures correlating to an increased risk of death.